2020 Contrast Media Market Assessment Report - Bayer and Daiichi Sankyo are the Leading Players
DUBLIN, March 23, 2020 /PRNewswire/ -- The "Global Contrast Media Market, by Product Type, by Application, by Modality, by Region, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
The Global Contrast Media Market size is expected to reach $6.3 billion by 2025, rising at a market growth of 3.52% CAGR during the forecast period.
The contrast media market is still in the growing phase but will evolve significantly in the years to come. The factors attributing to market growth include an increase in image-guided surgical procedures, improvements in medical technology, an increase in diagnostic imaging, and an increase in cancer and cardiac disorder rates.
Various factors such as the rise in acceptability for contrast agents and the increasing number of diagnostic centers that have expanded diagnostic imaging services contribute to the growth of the market. Several advanced methods, such as the technologies used in MRI imaging is a gas microbubble, are likely to boost the market growth. Factors including growing investments in the contrast media market and the changes in the radiopharmaceuticals and healthcare sector are fueling the market growth.
In several radiology procedures, the iodinated and gadolinium-based contrast media are used frequently. These agents are often crucial to providing an accurate diagnosis and are almost always effective and safe when properly administered. Reactions to contrast media, nevertheless, do occur and may be life-threatening. Hence, understanding how reactions to contrast agents manifest and how to handle them promptly are important for the faculty and personnel.
Gadolinium contrast media (sometimes referred to as an MRI contrast media, chemicals, or 'dyes') are chemical compounds used in MRI scans. When the gadolinium contrast medium is inserted into the body, it strengthens and boosts the accuracy of the MRI pictures (or images). It helps the radiologist (a specialist doctor qualified to examine the images and send the doctor or physician a written report) to report more precisely on how the body works and whether there is any illness or abnormality present.
The major strategies followed by the market participants are Product Launches and Partnerships. Based on the Analysis presented in the Cardinal matrix, Bayer AG and Daiichi Sankyo Company, Limited are some of the forerunners in the Contrast Media Market. Companies such as General Electric (GE) Co., The Guerbet Group, Bracco S.p.A., Trivitron Healthcare Pvt. Ltd., and Lantheus Holdings, Inc. are some of the key innovators in Contrast Media Market.
Partnerships, Collaborations & Agreements
-- Nov-2019: Guerbet came into partnership with InterSystems, a leader in
information technology platform particular for Healthcare. The
partnership was aimed at optimizing the combination of Contrast & Care
contrast media injection management solution into the IT systems of
hospitals and medical imaging centers.
-- Sep-2019: Guerbet partnered with IBM Watson. The partnership was aimed
at working on artificial intelligence software for diagnosing liver
cancer.
-- Jun-2019: Daiichi Sankyo signed an agreement with GE Healthcare. Under
this agreement, Daiichi transferred the exclusive development and
marketing rights in Japan for four diagnostics imaging agents to GE
Healthcare. It also transferred the marketing authorization rights in
Japan to GE Healthcare Pharma Limited.
-- Jan-2018: Trivitron signed a joint venture agreement with IFHA. This
joint agreement was focused on the African Continent. The joint venture
company provides turn-key solutions, medical services, engineering
support, etc. Both the companies have equal ownership in this JV.
Acquisitions & Mergers
-- Oct-2019: Lantheus Holdings signed an agreement to acquire Progenics
Pharmaceuticals. This acquisition brought the therapeutics and imaging
agents of the latter company to Lantheus. Its portfolio is expected to
complement the diagnostic capabilities of Lantheus.
-- Oct-2017: Bracco Imaging acquired SurgVision, a real-time fluorescence
image-guided surgery start-up. The acquisition helped the company in
becoming the most advanced company. The portfolio of SurgVision expanded
the imaging solutions of Bracco.
Product Launches & Expansions
-- Sep-2019: Bayer launched the Medrad Stellant Flex CT injection system.
This system provides individualized patient protocols and personalized
imaging for capital equipment with the company's TechCare program.
-- Feb-2019: Bayer introduced the MEDRAD Centargo CT injection system. This
is the latest addition to its range of imaging products.
-- Jul-2018: GE released Omnipaque (iohexol) Oral Solution in the US. This
is a new ready-to-drink contrast medium, which can be used to help the
physicians in diagnosing medical conditions through improving the
diagnostic visualization of the abdominal gastrointestinal tract.
-- Jul-2018: GE unveiled Clariscan (gadoteric acid), a new macrocyclic MRI
contrast agent in Korea. This launch expanded the company's foothold in
Korea. This is a gadolinium-based contrast agent, which has been
indicated for use with MRI in the brain, spine, and associated tissue in
adults. Earlier, in Mar-2017, GE launched this contrast agent in Europe.
-- Mar-2018: Guerbet introduced OptiVantage multi-use contrast media
injector in Europe. This injector was designed for injecting the
contrast agents used in computed tomography (CT) scan medical
examinations.
Key Topics Covered
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Contrast Media Market, by Product Type
1.4.2 Global Contrast Media Market, by Application
1.4.3 Global Contrast Media Market, by Modality
1.4.4 Global Contrast Media Market, by Geography
1.5 Methodology for the Research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Moves: (Product Launches and Product Expansions: Sep, 2019-Mar, 2015) Leading Players
Chapter 4. Global Contrast Media Market by Product Type
4.1 Global Iodinated Market by Region
4.2 Global Barium-based Market by Region
4.3 Global Gadolinium-based Market by Region
4.4 Global Microbubble Market by Region
Chapter 5. Global Contrast Media Market by Application
5.1 Global Neurological disorders Market by Region
5.2 Global Cancer Market by Region
5.3 Global Cardiovascular disorders Market by Region
5.4 Global Gastrointestinal disorders Market by Region
5.5 Global Nephrological disorders Market by Region
5.6 Global Musculoskeletal disorders Market by Region
5.7 Global Other Applications Market by Region
Chapter 6. Global Contrast Media Market by Modality
6.1 Global X-ray/CT Market by Region
6.2 Global MRI Market by Region
6.3 Global Ultrasound Market by Region
Chapter 7. Global Contrast Media Market by Region
7.1 North America Contrast Media Market
7.2 Europe Contrast Media Market
7.3 Asia-Pacific Contrast Media Market
7.4 LAMEA Contrast Media Market
Chapter 8. Company Profiles
8.1 Bayer AG
8.2 General Electric (GE) Co. (GE Healthcare)
8.3 The Guerbet Group
8.4 Lantheus Holdings, Inc.
8.5 Bracco S.p.A.
8.6 Trivitron Healthcare Pvt. Ltd.
8.7 Nano Therapeutics Pvt. Ltd.
8.8 Magnus Health, LLC (Veracross LLC)
8.9 Imax Diagnostic Imaging Limited
8.10 Daiichi Sankyo Company, Limited
For more information about this report visit https://www.researchandmarkets.com/r/l3tpk2
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/2020-contrast-media-market-assessment-report---bayer-and-daiichi-sankyo-are-the-leading-players-301028391.html
SOURCE Research and Markets
